Galectin Therapeutics Inc. (GALT)

[Chess Master]

REALIZE FDA DELAY = VERY POSITIVE - We dont know what they filed with the FDA because they never told us being the wonderful communicators that they are. what we do know is that whatever it was it was probably bad. The track record GALT has on clinical trial design is horrendous. RESULTS are Phenomenal but the DESIGNS always suck. They were going to probably have a 2 year study with a read out in year 3. Now shareholders have a chance. they could stop the trial on some people early once they show efficacy.

Shlevin messed the timing and trial up dont give him or the other directors a chance - do not vote for them.